Glycostasis, Inc. announced it raised $150,000 in an initial filing from an offering of $2.68 Million

Jun 11, 2015•about 10 years ago

Amount Raised

$150,000

Round Type

pre-seed

WashingtonBiotechnology

Company Information

Company

Glycostasis, Inc.

Location

Washington, United States

About

Glycostasis has engineered a human protein to release insulin when blood glucose levels rise.

Based on industry data

Tech investment trends

83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech